letibotulinumtoxinA-wlbg

FDA Drug Profile — LETYBO

letibotulinumtoxinA-wlbg is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including LETYBO. Available dosage form: injection, powder, lyophilized, for solution.

Drug Details

Generic Name
letibotulinumtoxinA-wlbg
Brand Names
LETYBO
Application Number
BLA761225
Sponsor
Hugel, Inc.
NDC Codes
2
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients
LETIBOTULINUMTOXINA

Indications and Usage

1 INDICATIONS AND USAGE LETYBO is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. LETYBO is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. ( 1 )